President Trump announces major changes to prescription drug pricing, with Pfizer leading the way. Discover how U.S. patients will benefit from this new initiative and what it means for the future of healthcare.
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
